I first noticed this one about 5-6 years ago and I thought they were focused on xenografts for bone tissue regeneration. I remember this as I was completing a thesis on the topic using synthetic scaffolds and my view was that xenografts were only a stop gap until resorbable synthetics improved, so I haven't really looked at them since.
There's no mention of this now....I quite like their pipeline. I see potential with orals. Might be worth watching to see if they can get some alternative funding arrangement.
